Fingerprinting meningitis with lasers
Lasers used in meningitis tests by Strathclyde University scientists
Researchers in the UK have developed a new method that uses surface enhanced Raman scattering (SERS) to quickly identify which meningitis causing bacteria is responsible for an infection.
Onset of meningitis is often rapid and severe, particularly when a bacterial infection is the cause. Several types of bacteria cause meningitis and each is sensitive to different antibiotics.
The faster the type of bacteria can be identified by DNA analysis, the faster patients can receive the most effective antibiotic for their condition. This also reduces the need for broadband antibiotics, overuse of which is increasing bacterial resistance.
Karen Faulds’ group at the University of Strathclyde, Glasgow, used SERS, a spectroscopic imaging technique, to identify which of Haemophilus influenzae, Streptococcus pneumoniae and Neisseria meningitidisis were present in a single sample, with a view to analysing cerebral spinal fluid from patients suspected to have meningitis. A series of DNA probes containing dyes detectable by SERS make it possible to single out the different pathogens.
‘The great advantage of SERS is this multiplexing capability,’ says Faulds. ‘This technique gives sharp, recognisable signals, like finger printing, so we can more easily discriminate what analytes are present in a mixture.’
Combining the SERS technique with chemometrics means the amount of bacteria in a sample can be measured whilst simultaneously identifying the bacteria. This would be particularly useful where co-infection of multiple species is common. Identifying the dominant pathogen present would allow targeted treatment.
‘Each individual pathogen in a mixture can be consistently identified and quantified much faster than conventional culture based methods,’ says Yiping Cui, director of the Advanced Photonic Center at Southeast University in Nanjing, China. ‘This facilitates the determination of a more effective course of treatment.’
Marc Porter, whose group at the University of Utah in the US uses SERS to examine biomarkers, says the ability to identify and concurrently quantify three common meningitis bacterial pathogens is impressive. ‘The work takes an important step in moving SERS and nanoparticle-based signalling much closer to meeting a critical need in pathogen detection,’ he adds.
K Gracie et al, Chem. Science, 2014, DOI: 10.1039/c3sc52875h
Source: Chemistry World /...
Previous Story: European Innovation Convention 2014
Next Story: Researchers Hijack Cancer Migration Mechanism to “Move” Brain Tumours
The Institute of Nanotechnology puts significant effort into ensuring that the information provided on its news pages is accurate and up-to-date. However, we cannot guarantee absolute accuracy. Consequently, the Institute of Nanotechnology disclaims any and all responsibility for inaccuracy, omission or any kind of deficiency in relation to the news items and articles hosted herein.
- 29 July 2014Nanotechnology and tyres: Greening industry and transport
- 22 July 2014Supporting Recommendations for Future Topics in Horizon 2020
- 17 June 20142014 edition of European NanoSafety Cluster Compendium now online
- 14 May 2014Gold nanoparticles for cancer treatment
- 22 April 2014Irish Materials Research Centre (AMBER) in World First Graphene Innovation
- View All